Targeting the MEK and STAT3 Pathways in Combination With PD1 Blockade Immunotherapy in KRAS-mutant Pancreatic Cancer

被引：0
|
作者：
Mehra, S. [1 ]
Lamichhane, P. [1 ,2 ]
Messaggio, F. [1 ]
Dai, X. [1 ]
Dosch, A. [1 ]
Willobee, B. [1 ]
Srinivasan, S. [1 ]
VanSaun, M. N. [1 ,3 ]
Nagathihalli, N. [1 ,3 ]
Merchant, N. [1 ,3 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA
[2] LECOM Sch Dent Med, Bradenton, FL USA
[3] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1490 / 1490
页数：1
相关论文
共 50 条
  • [21] DSP502-A NOVEL APPROACH FOR TARGETING TIGIT AND PD1 PATHWAYS FOR CANCER IMMUNOTHERAPY
    Chajut, Ayelet
    Greenwald, Shirley
    Weber, Matthew
    Tamir, Ami
    Pecker, Iris
    Tabakman, Rinat
    Ganthous, Lucy
    Tamir, Liat
    Kahn, Roy
    Avichzer, Jasmine
    Aronin, Alexandra
    Zorde-Khvalevsky, Elina
    Peled, Amnon
    Dranitzki, Michal Michal Elhalel
    Foley-Comer, Adam
    Tykocinski, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A825 - A825
  • [22] Rational combination of cancer therapies with PD1 axis blockade
    Thommen, Daniela S.
    Peeper, Daniel S.
    NATURE REVIEWS CANCER, 2024,
  • [23] Combined MEK and STAT3 inhibition reprograms the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer
    Garrido, Vanessa Tonin
    Datta, Jashodeep
    Dai, Xizi
    Bianchi, Anna
    Silva, Iago De Castro
    Lamichhane, Purushottam
    Mehra, Siddharth
    Singh, Samara P.
    Dosch, Austin R.
    Umland, Oliver
    VanSaun, Michael N. N.
    Hosein, Peter J.
    Nagathihalli, Nagaraj
    Merchant, Nipun
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer
    Alem, Diego
    Yang, Xinrui
    Beato, Francisca
    Sarcar, Bhaswati
    Tassielli, Alexandra F.
    Dai, Ruifan
    Hogenson, Tara L.
    Park, Margaret A.
    Jiang, Kun
    Cai, Jianfeng
    Yuan, Yu
    Fernandez-Zapico, Martin E.
    Tan, Aik Choon
    Fleming, Jason B.
    Xie, Hao
    MOLECULAR CARCINOGENESIS, 2023, 62 (07) : 1025 - 1037
  • [25] Immunotherapy against breast cancer based on Stat3 blockade
    De Martino, Mara
    Florencia Mercogliano, Maria
    Tkach, Mercedes
    Venturutti, Leandro
    Virginia Elizalde, Patricia
    Schillaci, Roxana
    CANCER RESEARCH, 2015, 75
  • [26] Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma
    Sahu, Nisebita
    Chan, Emily
    Chu, Felix
    Pham, Thinh
    Koeppen, Hartmut
    Forrest, William
    Merchant, Mark
    Settleman, Jeff
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (09) : 1729 - 1738
  • [27] STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
    D'Amico, Stephen
    Kirillov, Varvara
    Petrenko, Oleksi
    Reich, Nancy C.
    ELIFE, 2024, 13
  • [28] Combination therapies with CDK4/6 inhibitors to treat KRAS-mutant pancreatic cancer
    Goodwin, Craig M.
    Javaid, Sehrish
    Waters, Andrew M.
    Papke, Bjoern
    Yang, Runying
    Pierobon, Mariaelena
    Freed, Daniel M.
    Roberts, Patrick J.
    Cox, Adrienne D.
    Wood, Kris C.
    Petricoin, Emanuel F.
    Mcree, Autumn J.
    Der, Channing J.
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Targeting the immune-microenvironment with combined inhibition of MEK and STAT3 in a mouse model of pancreatic cancer
    Roberts, Casey
    VanSaun, Michael N.
    Lamichhane, Purushottam
    Messaggio, Fanuel
    Kovacs, Krisztina
    Srinivasan, Supriya
    Dai, Xizi
    Barretta, Jennifer
    Nagathihalli, Nagaraj
    Merchant, Nipun B.
    CANCER RESEARCH, 2016, 76
  • [30] Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
    Goodwin, Craig M.
    Waters, Andrew M.
    Klomp, Jennifer E.
    Javaid, Sehrish
    Bryant, Kirsten L.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Papke, Bjoern
    Yang, Runying
    Amparo, Amber M.
    Ozkan-Dagliyan, Irem
    Baldelli, Elisa
    Calvert, Valerie
    Pierobon, Mariaelena
    Sorrentino, Jessica A.
    Beelen, Andrew P.
    Bublitz, Natalie
    Luethen, Mareen
    Wood, Kris C.
    Petricoin III, Emanuel F.
    Sers, Christine
    McRee, Autumn J.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2023, 83 (01) : 141 - 157
12345